Good day, everyone, and welcome to today's Neurocrine Biosciences reports Q4 and fiscal year 2024 Earnings Call. (Operator Instructions) Please note today's call will be recorded and I will be ...
Jessica Batt; Vice President, ESG; Maximus Inc. Bruce Caswell; President, Chief Executive Officer, Director; Maximus Inc. David Mutryn; Chief Financial Officer, Trea ...